The Salk Institute announced that globally renowned neuroscientist Kay Tye will join its faculty in January 2019 as a full professor. She is currently an associate professor in the department of brain and cognitive sciences, part of the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology (MIT).
Tye focuses on a wide variety of cutting-edge technologies and approaches to better understand the brain circuitry underlying emotion and motivation. Her discoveries are helping pave the way for more targeted and efficient treatments for brain disorders, such as addiction-related behaviors, attention deficit disorder, anxiety and depression. For example, she has examined how emotional states such as increased anxiety may increase the propensity for substance abuse by facilitating long-term changes associated with reward-related learning.
Tye is the recipient of numerous accolades and grants, including a Presidential Early Career Award for Scientists and Engineers; an NIH Director’s Pioneer Award; an NIH Director’s New Innovator Award; a Society for Neuroscience Young Investigator Award; the Daniel X. Freedman Prize; a McKnight Fellowship; and many others. She received her BS degree from MIT and her PhD from UC San Francisco, before working as a postdoctoral fellow at Stanford University and the Ernest Gallo Clinic and Research Center.
In addition, the Salk Institute is honored to welcome Dannielle Engle back to Salk as an assistant professor in the Salk Cancer Center. She is currently a senior fellow at Cold Spring Harbor Laboratory, in New York, where she focuses on the early detection and treatment of pancreatic cancer. Engle conducted research in the lab of Salk Professor Geoffrey Wahl for six years as part of her doctoral program at UC San Diego.
Pancreatic cancer is one of the deadliest cancers because it is difficult to detect and is especially resistant to treatment. As part of her postdoctoral training with David A. Tuveson at Cambridge Research Institute (UK) and Cold Spring Harbor Laboratory, Engle developed miniature pancreas organ cultures (“organoids”) using both human and mouse cells to identify biomarkers and treatments for pancreatic cancer.
Engle holds a bachelor’s degree in biological sciences and Asian studies from Northwestern University and a doctorate in biological sciences from UC San Diego. She is the recipient of a California Breast Cancer Research Program Fellowship, a UC San Diego Chancellor’s Fellowship and a National Institutes of Health/National Cancer Institute Career Transition Award, among other honors. She begins her appointment in January 2019.